Tilray leads the European medical cannabis market and aims to broaden access through a new partnership involving Italy, Portugal, and Poland.
3 reports, 2 independent
Updated Aug 10
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tilray leads the European medical cannabis market and aims to broaden access through a new partnership involving Italy, Portugal, and Poland.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tilray
pharmaceutical and cannabis company
-
Italy
country in southern Europe
-
Portugal
country in Southwestern Europe
-
Poland
country in Central Europe
Related events
- Tilray launched new medical cannabis strains in Germany, aiming to improve access in Europe's largest market.
- Tilray secured a partnership to distribute medical cannabis products in Italy, while Trump's administration considers reclassifying cannabis.
- Aurora Cannabis and Tilray are driving market growth and leading innovations in European cannabis therapies.
Coverage
Newest first; wire copies grouped- fool.com
- GlobeNewswireTilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance D
- Unknown outlet